Friday, July 1st | 2 Tammuz 5782

March 24, 2020 11:22 am

Israel Chemicals Donates Money, Swabs to Bolster Battle Against Covid-19 in Israel

avatar by Adi Pick / CTech

A medical worker wearing a protective mask and suit treats patients suffering from coronavirus disease (COVID-19) in an intensive care unit at the Oglio Po hospital in Cremona, Italy, March 19, 2020. Photo: Reuters / Flavio Lo Scalzo.

CTech – Tel Aviv-headquartered Israel Chemicals (ICL), with the help of the regional managers of its factories in China, is importing 20,000 swabs for the diagnosis of coronavirus (Covid-19) cases in Israel, the company announced Sunday. ICL also donated NIS 900,000 (approximately $247,000) to Israeli hospitals Soroka University Medical Center in Israel’s south and Chaim Sheba Medical Center in the Tel Aviv area.

The swabs, for which the company reported costs of NIS 200,000 (approximately $50,000), were pre-approved by Israel’s Ministry of Health.

Dual-listed on the NYSE and the Tel Aviv Stock Exchange, ICL is an industrial company focusing on agriculture, food, and engineered materials. The company is controlled by its largest shareholder, Tel Aviv-listed Israel Corporation. ICL employs more than 11,000 people, and its 2019 revenue totaled approximately $5.3 billion.

Share this Story: Share On Facebook Share On Twitter

Let your voice be heard!

Join the Algemeiner

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.